OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Proteomics
(2)
Organisms
Andropogon gerardi
(2)
Bacteria
(2)
Bartonella quintana JK 31
(2)
Canis lupus familiaris
(2)
Clavibacter nebraskensis NCPPB 2581
(2)
Cnidaria
(2)
Ensifer adhaerens
(2)
Human alphaherpesvirus 1 strain 17
(2)
Human alphaherpesvirus 1 strain KOS
(2)
Human betaherpesvirus 5
(2)
Human herpesvirus 2 strain 186
(2)
Mesocricetus auratus
(2)
Miscanthus x giganteus
(2)
Mus musculus
(2)
Panicum virgatum
(2)
Platyhelminthes
(2)
Pseudomonas aeruginosa PA103
(2)
Rabies virus Nishigahara RCEH
(2)
Rattus norvegicus
(2)
Rattus rattus
(2)
Rhodococcus jostii RHA1
(2)
Rhodopseudomonas palustris
(2)
Shigella
(2)
Sorghastrum nutans
(2)
Streptococcus dysgalactiae subsp. equisimilis SK1249
(2)
Streptococcus pneumoniae
(2)
Streptomyces coelicolor A3(2)
(2)
Synechocystis sp. PCC 6803
(2)
Tripsacum dactyloides
(2)
Viruses
(2)
Repository
pride
(2)
Technology Type
Mass Spectrometry
(2)
Bottom-up proteomics
(1)
Top-down proteomics
(1)
Publication Date
2024
(1)
2022
(1)
Lab affiliation
Department of Biochemistry and Biophysics, University of Pennsylvania
(1)
Dr. Ben E Black, Department of Biochemistry and Biophysics, University of Pennsylvania
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
HXMS on PARP1+DNA+HPF1 to study the dynamics of PARP1
The project is about studying the dynamics of PARP1 when bound to DNA and HPF1.
ORGANISM(S):
Homo sapiens (Human)
2022-02-17
|
PXD026580
|
Pride
Hxms
Parp1
Hpf1
Dna
Cite
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks
The project is about studying the dynamics of PARP1 when bound to DNA and veliparib derivatives.
ORGANISM(S):
Homo sapiens (Human)
2024-03-19
|
PXD047072
|
Pride
Parp1
Parpi
Hdx-ms
Allostery
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
